Molecular modeling and docking studies of the oxytocin receptor

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Karpenko IA, Margathe JF, Rodriguez T et al. Selective nonpeptidic fluorescent ligands for oxytocin receptor: design, synthesis, and application to time-resolved FRET binding assay. J. Med. Chem. 58(5), 2547–2552 (2015).
  Medline CASGoogle Scholar
• 2 Feifel D, Shilling PD, Belcher AM. The effects of oxytocin and its analog, carbetocin, on genetic deficits in sensorimotor gating. Eur. Neuropsychopharmacol. 22(5), 374–378 (2012).
  Medline CASGoogle Scholar
• 3 Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol. Rev. 81, 629–683 (2001).
  Medline CASGoogle Scholar
• 4 Jojart B, Balogh B, Marki A. Modeling the human oxytocin receptor for drug discovery efforts. Exp. Opin. Drug Discov. 2(12), 1579–1590 (2007).
  Medline CASGoogle Scholar
• 5 Carson DS, Guastella AJ, Taylor ER, McGregor IS. A brief history of oxytocin and its role in modulating psychostimulant effects. J. Psychopharmacol. 27(3), 231–247 (2013). •• This paper is of considerable interest since it indicates that oxytocin attenuates a broad number of cocaine and methamphetamine-induced behaviors and associated neuronal activity in rodents.
  Medline CASGoogle Scholar
• 6 Zingg HH, Laporte SA. The oxytocin receptor. Trends Endocrinol. Metab. 14(5), 222–227 (2003).
  Medline CASGoogle Scholar
• 7 Yang Y, Li H, Ward R, Gao L, Wei JF, Xu TR. Novel oxytocin receptor agonists and antagonists: a patent review (2002–2013). Expert Opin. Ther. Pat. 24(1), 29–46 (2014).
  MedlineGoogle Scholar
• 8 Barberis C, Mouillac B, Durroux T. Structural bases of vasopressin/oxytocin receptor function. J. Endocrinol. 156(2), 223–229 (1998).
  Medline CASGoogle Scholar
• 9 Protter. http://wlab.ethz.ch/protter/start/
  Google Scholar
• 10 UniProt. www.uniprot.org/
  Google Scholar
• 11 BLAST. https://blast.ncbi.nlm.nih.gov/Blast.cgi
  Google Scholar
• 12 Ballesteros JA, Shi L, Javitch JA. Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure–function analysis of rhodopsin-like receptors. Mol. Pharmacol. 60(1), 1–19 (2001). •• Classic paper in the field of G-protein-coupled receptor modeling.
  Medline CASGoogle Scholar
• 13 Warne T, Moukhametzianov R, Baker JG et al. The structural basis for agonist and partial agonist action on a beta(1)-adrenergic receptor. Nature 469(7329), 241–244 (2011).
  Medline CASGoogle Scholar
• 14 Miller-Gallacher JL, Nehme R, Warne T et al. The 2.1 A resolution structure of cyanopindolol-bound beta1-adrenoceptor identifies an intramembrane Na⁺ ion that stabilises the ligand-free receptor. PLoS ONE 9(3), e92727 (2014).
  MedlineGoogle Scholar
• 15 Ring AM, Manglik A, Kruse AC et al. Adrenaline-activated structure of beta2-adrenoceptor stabilized by an engineered nanobody. Nature 502(7472), 575–579 (2013).
  Medline CASGoogle Scholar
• 16 Abagyan R, Totrov M, Kuznetsov DN. ICM – a new method for protein modeling and design. Applications to docking and structure prediction from the distorted native comformation. J. Comp. Chem. 15, 488–506 (1994). •• Paper describing the ICM program, which was the main program used in this study.
  CASGoogle Scholar
• 17 Abagyan R, Totrov M. Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins. J. Mol. Biol. 235(3), 983–1002 (1994).
  Medline CASGoogle Scholar
• 18 Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26(2), 283–291 (1993).
  CASGoogle Scholar
• 19 Hooft RW, Vriend G, Sander C, Abola EE. Errors in protein structures. Nature 381(6580), 272 (1996). • Interesting paper since it highlights the possibility of errors in protein structures deposited in the Protein Data Bank.
  Medline CASGoogle Scholar
• 20 Colovos C, Yeates TO. Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci. 2(9), 1511–1519 (1993).
  Medline CASGoogle Scholar
• 21 Vriend G. WHAT IF: a molecular modeling and drug design program. J. Mol. Graph. 8(1), 52–56, 29 (1990).
  Medline CASGoogle Scholar
• 22 Rosse G. Pyrazolsulfonamide agonists of oxytocin receptor. ACS Med. Chem. Lett. 5(11), 1188–1189 (2014).
  Medline CASGoogle Scholar
• 23 Kufareva I, Chen YC, Ilatovskiy AV, Abagyan R. Compound activity prediction using models of binding pockets or ligand properties in 3D. Curr. Top. Med. Chem. 12(17), 1869–1882 (2012).
  Medline CASGoogle Scholar
• 24 Rose JP, Wu CK, Hsiao CD, Breslow E, Wang BC. Crystal structure of the neurophysin-oxytocin complex. Nat. Struct. Biol. 3(2), 163–169 (1996).
  Medline CASGoogle Scholar
• 25 Klebe G. Virtual ligand screening: strategies, perspectives and limitations. Drug Discov. Today 11(13–14), 580–594 (2006). •• This is a highly interesting paper that thoroughly summarizes the concepts and prerequisites to perform virtual screening.
  Medline CASGoogle Scholar
• 26 Kitchen DB, Decornez H, Furr JR, Bajorath J. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat. Rev. Drug Discov. 3(11), 935–949 (2004).
  Medline CASGoogle Scholar
• 27 Bhattacharya A, Wunderlich Z, Monleon D, Tejero R, Montelione GT. Assessing model accuracy using the homology modeling automatically software. Proteins 70(1), 105–118 (2008).
  Medline CASGoogle Scholar
• 28 Worth CL, Kleinau G, Krause G. Comparative sequence and structural analyses of G-protein-coupled receptor crystal structures and implications for molecular models. PLoS ONE 4(9), e7011 (2009).
  MedlineGoogle Scholar
• 29 Wesley VJ, Hawtin SR, Howard HC, Wheatley M. Agonist-specific, high-affinity binding epitopes are contributed by an arginine in the N-terminus of the human oxytocin receptor. Biochemistry 41(16), 5086–5092 (2002).
  Medline CASGoogle Scholar
• 30 Hawtin SR, Howard HC, Wheatley M. Identification of an extracellular segment of the oxytocin receptor providing agonist-specific binding epitopes. Biochem. J. 354(Pt 2), 465–472 (2001).
  Medline CASGoogle Scholar
• 31 Morris AL, MacArthur MW, Hutchinson EG, Thornton JM. Stereochemical quality of protein structure coordinates. Proteins 12(4), 345–364 (1992).
  Medline CASGoogle Scholar
• 32 Shahlaei M, Madadkar-Sobhani A, Mahnam K, Fassihi A, Saghaie L, Mansourian M. Homology modeling of human CCR5 and analysis of its binding properties through molecular docking and molecular dynamics simulation. Biochim. Biophys. Acta 1808(3), 802–817 (2011).
  Medline CASGoogle Scholar
• 33 Koehbach J, Stockner T, Bergmayr C, Muttenthaler M, Gruber CW. Insights into the molecular evolution of oxytocin receptor ligand binding. Biochem. Soc. Trans. 41(1), 197–204 (2013).
  Medline CASGoogle Scholar
• 34 Slusarz MJ, Slusarz R, Ciarkowski J. Molecular dynamics simulation of human neurohypophyseal hormone receptors complexed with oxytocin-modeling of an activated state. J. Pept. Sci. 12(3), 171–179 (2006).
  Medline CASGoogle Scholar
• 35 Favre N, Fanelli F, Missotten M et al. The DRY motif as a molecular switch of the human oxytocin receptor. Biochemistry 44(30), 9990–10008 (2005).
  Medline CASGoogle Scholar
• 36 Fanelli F, Barbier P, Zanchetta D, de Benedetti PG, Chini B. Activation mechanism of human oxytocin receptor: a combined study of experimental and computer-simulated mutagenesis. Mol. Pharmacol. 56(1), 214–225 (1999).
  Medline CASGoogle Scholar
• 37 Schwartz TW, Frimurer TM, Holst B, Rosenkilde MM, Elling CE. Molecular mechanism of 7TM receptor activation – a global toggle switch model. Annu. Rev. Pharmacol. Toxicol. 46, 481–519 (2006).
  Medline CASGoogle Scholar
• 38 UCLA Structure Analysis and Verification Server. https://services.mbi.ucla.edu/SAVES/
  Google Scholar